Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Injectable NAD+ is not FDA-approved as a therapeutic
Consequently, the levels of acetylcholinesterase in brain are diminished within the liposomal treatment group and elevated in rotenone treated group
We accept HSA and FSA payments, and provide detailed receipts for your records
Directed evolution of LaccID: generation 3 For the third round of evolution, three libraries were generated using G2 (LacAnc100 + Q45R;R121S) as the starting template
273 Astrocytes infected with the virus demonstrated signs of reactivity, increased cytokine production and cellular stress
US$ 21.24
US$ 20.18
US$ 28.01
US$ 26.71
US$ 23.72
US$ 25.93
US$ 24.82
